Free Trial

National Vision (EYE) Competitors

National Vision logo
$15.44 -0.06 (-0.39%)
Closing price 06/5/2026 04:00 PM Eastern
Extended Trading
$15.31 -0.13 (-0.86%)
As of 06/5/2026 07:57 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

EYE vs. NVST, STVN, LQDA, LIVN, and IRTC

Should you buy National Vision stock or one of its competitors? MarketBeat compares National Vision with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with National Vision include Envista (NVST), Stevanato Group (STVN), Liquidia (LQDA), LivaNova (LIVN), and iRhythm Technologies (IRTC). These companies are all part of the "medical equipment" industry.

How does National Vision compare to Envista?

National Vision (NASDAQ:EYE) and Envista (NYSE:NVST) are both medical equipment companies, but which is the superior business? We will compare the two companies based on the strength of their valuation, earnings, dividends, institutional ownership, profitability, analyst recommendations, risk and media sentiment.

National Vision has a beta of 1.07, suggesting that its stock price is 7% more volatile than the broader market. Comparatively, Envista has a beta of 0.88, suggesting that its stock price is 12% less volatile than the broader market.

National Vision currently has a consensus price target of $30.08, indicating a potential upside of 94.84%. Envista has a consensus price target of $28.83, indicating a potential upside of 24.94%. Given National Vision's stronger consensus rating and higher probable upside, research analysts plainly believe National Vision is more favorable than Envista.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
National Vision
0 Sell rating(s)
5 Hold rating(s)
7 Buy rating(s)
0 Strong Buy rating(s)
2.58
Envista
0 Sell rating(s)
9 Hold rating(s)
6 Buy rating(s)
0 Strong Buy rating(s)
2.40

In the previous week, National Vision had 3 more articles in the media than Envista. MarketBeat recorded 3 mentions for National Vision and 0 mentions for Envista. National Vision's average media sentiment score of 1.11 beat Envista's score of 0.50 indicating that National Vision is being referred to more favorably in the media.

Company Overall Sentiment
National Vision Positive
Envista Positive

Envista has higher revenue and earnings than National Vision. National Vision is trading at a lower price-to-earnings ratio than Envista, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
National Vision$1.99B0.62$29.60M$0.5727.09
Envista$2.72B1.38$47M$0.4156.29

Envista has a net margin of 2.41% compared to National Vision's net margin of 2.31%. Envista's return on equity of 7.11% beat National Vision's return on equity.

Company Net Margins Return on Equity Return on Assets
National Vision2.31% 6.41% 2.81%
Envista 2.41%7.11%3.91%

Summary

National Vision and Envista tied by winning 7 of the 14 factors compared between the two stocks.

How does National Vision compare to Stevanato Group?

Stevanato Group (NYSE:STVN) and National Vision (NASDAQ:EYE) are both medical equipment companies, but which is the superior business? We will contrast the two companies based on the strength of their profitability, institutional ownership, dividends, valuation, media sentiment, analyst recommendations, earnings and risk.

Stevanato Group has a beta of 0.78, indicating that its stock price is 22% less volatile than the broader market. Comparatively, National Vision has a beta of 1.07, indicating that its stock price is 7% more volatile than the broader market.

Stevanato Group has higher earnings, but lower revenue than National Vision. National Vision is trading at a lower price-to-earnings ratio than Stevanato Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Stevanato Group€1.20B4.68€158.21M€0.5931.49
National Vision$1.99B0.62$29.60M$0.5727.09

In the previous week, Stevanato Group had 2 more articles in the media than National Vision. MarketBeat recorded 5 mentions for Stevanato Group and 3 mentions for National Vision. National Vision's average media sentiment score of 1.11 beat Stevanato Group's score of 0.57 indicating that National Vision is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Stevanato Group
1 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
National Vision
2 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

National Vision has a consensus target price of $30.08, indicating a potential upside of 94.84%. Given National Vision's higher possible upside, analysts clearly believe National Vision is more favorable than Stevanato Group.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Stevanato Group
1 Sell rating(s)
1 Hold rating(s)
3 Buy rating(s)
1 Strong Buy rating(s)
2.67
National Vision
0 Sell rating(s)
5 Hold rating(s)
7 Buy rating(s)
0 Strong Buy rating(s)
2.58

Stevanato Group has a net margin of 11.76% compared to National Vision's net margin of 2.31%. Stevanato Group's return on equity of 10.27% beat National Vision's return on equity.

Company Net Margins Return on Equity Return on Assets
Stevanato Group11.76% 10.27% 6.08%
National Vision 2.31%6.41%2.81%

Summary

Stevanato Group beats National Vision on 10 of the 15 factors compared between the two stocks.

How does National Vision compare to Liquidia?

National Vision (NASDAQ:EYE) and Liquidia (NASDAQ:LQDA) are both medical equipment companies, but which is the better business? We will compare the two businesses based on the strength of their earnings, institutional ownership, dividends, risk, profitability, analyst recommendations, valuation and media sentiment.

National Vision has a beta of 1.07, indicating that its share price is 7% more volatile than the broader market. Comparatively, Liquidia has a beta of 0.58, indicating that its share price is 42% less volatile than the broader market.

64.5% of Liquidia shares are owned by institutional investors. 2.4% of National Vision shares are owned by insiders. Comparatively, 25.6% of Liquidia shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

National Vision currently has a consensus price target of $30.08, indicating a potential upside of 94.84%. Liquidia has a consensus price target of $55.63, indicating a potential downside of 10.06%. Given National Vision's higher possible upside, equities analysts clearly believe National Vision is more favorable than Liquidia.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
National Vision
0 Sell rating(s)
5 Hold rating(s)
7 Buy rating(s)
0 Strong Buy rating(s)
2.58
Liquidia
2 Sell rating(s)
0 Hold rating(s)
6 Buy rating(s)
3 Strong Buy rating(s)
2.91

In the previous week, Liquidia had 3 more articles in the media than National Vision. MarketBeat recorded 6 mentions for Liquidia and 3 mentions for National Vision. National Vision's average media sentiment score of 1.11 beat Liquidia's score of -0.45 indicating that National Vision is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
National Vision
2 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Liquidia
2 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

National Vision has higher revenue and earnings than Liquidia. National Vision is trading at a lower price-to-earnings ratio than Liquidia, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
National Vision$1.99B0.62$29.60M$0.5727.09
Liquidia$158.32M34.74-$68.92M$0.14441.79

Liquidia has a net margin of 7.74% compared to National Vision's net margin of 2.31%. Liquidia's return on equity of 46.82% beat National Vision's return on equity.

Company Net Margins Return on Equity Return on Assets
National Vision2.31% 6.41% 2.81%
Liquidia 7.74%46.82%7.06%

Summary

Liquidia beats National Vision on 10 of the 17 factors compared between the two stocks.

How does National Vision compare to LivaNova?

National Vision (NASDAQ:EYE) and LivaNova (NASDAQ:LIVN) are both medical equipment companies, but which is the better business? We will contrast the two companies based on the strength of their institutional ownership, earnings, media sentiment, valuation, profitability, dividends, risk and analyst recommendations.

In the previous week, National Vision and National Vision both had 3 articles in the media. National Vision's average media sentiment score of 1.11 beat LivaNova's score of 0.26 indicating that National Vision is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
National Vision
2 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
LivaNova
0 Very Positive mention(s)
1 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

National Vision has higher revenue and earnings than LivaNova. National Vision is trading at a lower price-to-earnings ratio than LivaNova, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
National Vision$1.99B0.62$29.60M$0.5727.09
LivaNova$1.39B2.86-$242.47M$1.9537.11

LivaNova has a net margin of 7.48% compared to National Vision's net margin of 2.31%. LivaNova's return on equity of 16.48% beat National Vision's return on equity.

Company Net Margins Return on Equity Return on Assets
National Vision2.31% 6.41% 2.81%
LivaNova 7.48%16.48%7.59%

National Vision has a beta of 1.07, meaning that its share price is 7% more volatile than the broader market. Comparatively, LivaNova has a beta of 0.88, meaning that its share price is 12% less volatile than the broader market.

97.6% of LivaNova shares are held by institutional investors. 2.4% of National Vision shares are held by company insiders. Comparatively, 0.4% of LivaNova shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

National Vision currently has a consensus price target of $30.08, indicating a potential upside of 94.84%. LivaNova has a consensus price target of $79.38, indicating a potential upside of 9.69%. Given National Vision's higher possible upside, analysts plainly believe National Vision is more favorable than LivaNova.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
National Vision
0 Sell rating(s)
5 Hold rating(s)
7 Buy rating(s)
0 Strong Buy rating(s)
2.58
LivaNova
0 Sell rating(s)
3 Hold rating(s)
6 Buy rating(s)
0 Strong Buy rating(s)
2.67

Summary

LivaNova beats National Vision on 8 of the 15 factors compared between the two stocks.

How does National Vision compare to iRhythm Technologies?

National Vision (NASDAQ:EYE) and iRhythm Technologies (NASDAQ:IRTC) are both medical equipment companies, but which is the better business? We will contrast the two companies based on the strength of their risk, analyst recommendations, institutional ownership, valuation, profitability, media sentiment, earnings and dividends.

National Vision has a net margin of 2.31% compared to iRhythm Technologies' net margin of -3.53%. National Vision's return on equity of 6.41% beat iRhythm Technologies' return on equity.

Company Net Margins Return on Equity Return on Assets
National Vision2.31% 6.41% 2.81%
iRhythm Technologies -3.53%-10.26%-1.39%

National Vision presently has a consensus target price of $30.08, suggesting a potential upside of 94.84%. iRhythm Technologies has a consensus target price of $189.69, suggesting a potential upside of 75.46%. Given National Vision's higher probable upside, equities research analysts plainly believe National Vision is more favorable than iRhythm Technologies.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
National Vision
0 Sell rating(s)
5 Hold rating(s)
7 Buy rating(s)
0 Strong Buy rating(s)
2.58
iRhythm Technologies
1 Sell rating(s)
1 Hold rating(s)
12 Buy rating(s)
2 Strong Buy rating(s)
2.94

National Vision has a beta of 1.07, meaning that its share price is 7% more volatile than the broader market. Comparatively, iRhythm Technologies has a beta of 1.27, meaning that its share price is 27% more volatile than the broader market.

In the previous week, iRhythm Technologies had 1 more articles in the media than National Vision. MarketBeat recorded 4 mentions for iRhythm Technologies and 3 mentions for National Vision. National Vision's average media sentiment score of 1.11 beat iRhythm Technologies' score of 0.91 indicating that National Vision is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
National Vision
2 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
iRhythm Technologies
3 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

National Vision has higher revenue and earnings than iRhythm Technologies. iRhythm Technologies is trading at a lower price-to-earnings ratio than National Vision, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
National Vision$1.99B0.62$29.60M$0.5727.09
iRhythm Technologies$747.14M4.75-$44.55M-$0.86N/A

Summary

National Vision beats iRhythm Technologies on 9 of the 15 factors compared between the two stocks.

Get National Vision News Delivered to You Automatically

Sign up to receive the latest news and ratings for EYE and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding EYE and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

EYE vs. The Competition

MetricNational VisionCONS PD IndustryStaples SectorNASDAQ Exchange
Market Cap$1.24B$30.26B$15.82B$12.42B
Dividend YieldN/A3.46%3.58%5.33%
P/E Ratio27.0967.0924.9923.63
Price / Sales0.621.4646.96124.83
Price / Cash8.6631.2016.3357.17
Price / Book1.4110.515.576.35
Net Income$29.60M$1.33B$676.04M$337.59M
7 Day Performance-7.82%6.27%-0.35%-2.51%
1 Month Performance-31.89%0.50%-3.23%-0.68%
1 Year Performance-26.58%-18.97%-12.83%25.37%

National Vision Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
EYE
National Vision
4.6456 of 5 stars
$15.44
-0.4%
$30.08
+94.8%
-26.0%$1.24B$1.99B27.0913,138
NVST
Envista
3.2365 of 5 stars
$24.05
+2.6%
$28.83
+19.9%
+23.5%$3.91B$2.72B58.6612,000
STVN
Stevanato Group
2.1458 of 5 stars
€18.12
+0.6%
N/A-19.9%€5.49B€1.34B30.726,010
LQDA
Liquidia
2.2221 of 5 stars
$61.01
+0.0%
$49.33
-19.1%
+243.2%$5.43B$158.32M435.8250
LIVN
LivaNova
2.7537 of 5 stars
$73.83
flat
$79.38
+7.5%
+61.3%$4.06B$1.39B37.863,300

Related Companies and Tools


This page (NASDAQ:EYE) was last updated on 6/6/2026 by MarketBeat.com Staff.
From Our Partners